Anti-HTRA-1 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody recognizing HTRA-1 (high-temperature requirement A serine peptidase 1), validated for Western blot across human and predicted rodent samples.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Pan, Monkey
UniProt
Q92743
Size
100ug
Cat. #
RP2HTRA1

In stock

SKU
RP-HTRA1

Options

As low as: $130.00

Target Overview

HTRA-1 (high-temperature requirement A serine peptidase 1, UniProt Q92743, EC 3.4.21.-) is a secreted and membrane-associated serine protease that cleaves extracellular matrix proteins and modulates growth factor signaling. The 480-residue enzyme degrades fibronectin, aggrecan, decorin, and fibromodulin, generating fragments that influence matrix remodeling and cellular responses. HTRA-1 also cleaves insulin-like growth factor-binding proteins to regulate IGF availability and inhibits TGF-beta family signaling in a catalytic activity-dependent manner, though whether TGF-beta proteins are direct substrates remains uncertain. Intracellularly, HTRA-1 degrades TSC2, activating downstream mTOR pathway components. The protease plays physiological roles in retinal angiogenesis, neuronal maturation, and cartilage homeostasis. Researchers study HTRA-1 in osteoarthritis, age-related macular degeneration, tumor biology, and renal pathology, where altered expression or activity correlates with disease progression.

Background

HTRA-1 belongs to the HtrA family of ATP-independent serine proteases characterized by trypsin-like protease domains and PDZ domains that regulate substrate recognition and oligomerization. The enzyme is secreted into the extracellular space and associates with the cell membrane, where it processes matrix components in response to cellular stress and developmental cues. Through fibronectin cleavage, HTRA-1 generates bioactive fragments that induce synovial cells to upregulate MMP1 and MMP3, amplifying matrix degradation in joint tissues. Proteoglycan cleavage releases soluble FGF-glycosaminoglycan complexes that modulate FGF signaling range and intensity. The TGF-beta inhibitory function requires an intact catalytic triad, implicating protease activity in the regulation of Smad-dependent and Smad-independent pathways that govern angiogenesis, fibrosis, and cell survival. Recent work has expanded HTRA-1 relevance beyond classical matrix biology. Giuffredi et al. mapped HTRA-1 expression dynamics during postnatal cartilage maturation, identifying stage-specific proteomic signatures linked to tissue development and osteoarthritis susceptibility. Zuckerman et al. described HTRA-1-associated membranous nephropathy with polytypic IgG deposition, suggesting a role in immune-mediated renal injury distinct from monoclonal gammopathies. Mirioglu et al. explored HTRA-1 as a potential recurrence predictor in giant cell tumor of bone, correlating expression levels with clinical outcomes. These findings underscore HTRA-1 as a context-dependent regulator in connective tissue, vasculature, and neoplastic settings. Triple Point Biologics offers four rabbit polyclonal antibodies raised against the Kazal-like domain of HTRA-1, validated for Western blot with predicted cross-reactivity in mouse, rat, and primate tissues. These reagents support investigation of HTRA-1 localization, expression, and functional outcomes across development, injury, and disease models.

References

  1. Giuffredi G et al (2026) Mapping articular cartilage maturation across postnatal development by proteomics. Osteoarthritis Cartilage. PubMed · 10.1016/j.joca.2026.06.006
  2. Zuckerman JE et al (2026) Serine Protease HTRA1 Membranous Nephropathy With Polytypic IgG Concurrent With Plasma Cell Dyscrasia. Kidney Med. PubMed · 10.1016/j.xkme.2026.101402
  3. Mirioglu A et al (2026) Giant cell tumor of bone: exploring HtrA1 as a potential predictor of recurrence. Arch Orthop Trauma Surg. PubMed · 10.1007/s00402-026-06374-5

Additional Specifications

Gene Symbol HTRA1
UniProt ID Q92743
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Pan, Monkey
Pack Size 100ug
Immunogen (Kazal-Like domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 98-157.
Immunogen (Catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 23-480.
Immunogen (PDZ domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 365-467.
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 430-480.
Alternate Names High-temperature requirement A serine peptidase 1, Serine protease HTRA1, Serine protease 11, L56, HTRA1, EC 3.4.21.-

Frequently Asked Questions

What is the expected molecular weight for HTRA-1 on Western blot?

The full-length HTRA-1 protein runs at approximately 50 kDa on reducing SDS-PAGE, corresponding to the 480-residue polypeptide plus glycosylation. Because HTRA-1 is secreted and undergoes N-glycosylation, you may observe a smear or band between 48–55 kDa depending on cell type and post-translational modification status. In conditioned media samples, processed or proteolytically cleaved forms occasionally appear as lower-molecular-weight bands. Deglycosylation with PNGase F will shift the band to approximately 48 kDa, confirming the glycosylated nature of the mature protein.

What starting dilution should I use for Western blot with this HTRA-1 antibody?

The recommended starting dilution is 1:1000 in blocking buffer for Western blot. This polyclonal antibody typically yields clean bands at that concentration when detecting HTRA-1 from whole-cell lysates or conditioned media. If your sample has low HTRA-1 expression or you are working with tissue lysates, start at 1:500 and titrate up to 1:2000 to balance signal intensity and background. Overnight incubation at 4°C often improves sensitivity compared to one-hour room-temperature binding. Always include a positive control lysate from RPE or fibroblast cells, which express HTRA-1 constitutively.

Does this antibody detect mouse and rat HTRA-1, or only human?

This antibody has been validated for human HTRA-1 and shows predicted cross-reactivity with mouse, rat, non-human primate, and Pan troglodytes based on sequence homology in the immunogen region. Human and mouse HTRA-1 share approximately 87% identity, so cross-reactivity is likely but should be confirmed in your hands with appropriate species-matched positive controls. If you plan to use mouse or rat samples, run a pilot blot at 1:500–1:1000 and compare signal to a validated human control. We have not performed formal validation in rodent models, so treat preliminary results as predicted until confirmed.

Can I use this HTRA-1 antibody for immunohistochemistry or immunofluorescence?

Yes, Triple Point Biologics antibodies are validated for Western blot and immunohistochemistry, and many perform well in immunofluorescence. For IHC on formalin-fixed paraffin-embedded tissue, antigen retrieval with citrate buffer (pH 6.0) at high temperature is typically required because HTRA-1 epitopes are masked by fixation. Start with a 1:100–1:200 dilution and optimize based on signal and background. For IF on cultured cells, try 1:100 after fixation with 4% paraformaldehyde and permeabilization with 0.1% Triton X-100. HTRA-1 localizes to secretory vesicles and the extracellular matrix in many cell types.

What sample types work best for detecting HTRA-1 with this antibody?

HTRA-1 is a secreted protease, so conditioned serum-free media from cultured cells often yield the strongest signal on Western blot. Collect media after 24–48 hours, concentrate 10–20-fold using centrifugal filters (10 kDa cutoff), and load 10–20 µg total protein per lane. Whole-cell lysates also work well, particularly from retinal pigment epithelial cells, fibroblasts, or osteoarthritic chondrocytes, which express HTRA-1 at moderate-to-high levels. Tissue lysates from placenta, skeletal muscle, or cartilage are suitable but may require more total protein. Use RIPA buffer with protease inhibitors; avoid boiling samples if studying oligomeric forms.

How should HTRA-1 antibody aliquots be stored to maintain long-term stability?

Store the antibody at –20°C in single-use aliquots to avoid repeated freeze-thaw cycles, which can reduce titre and increase aggregation. After the first thaw, the working aliquot can be kept at 4°C for up to one month if sodium azide (0.02–0.05%) is present as a preservative. Do not store diluted antibody in blocking buffer for more than one week; prepare fresh dilutions for critical experiments. If you observe a gradual loss of signal over time, it usually reflects freeze-thaw damage rather than lot-to-lot variation. Glycerol (50%) can be added to the stock for –20°C storage without freezing solid.

What controls should I include when detecting HTRA-1 in cell lysates or tissue?

Include a positive control lysate from ARPE-19 retinal pigment epithelial cells or primary human fibroblasts, both of which express HTRA-1 constitutively. For a negative control, use lysate from cells treated with HTRA-1-targeting siRNA or CRISPR knockout lines if available. Loading equal amounts of total protein (20–30 µg per lane) and probing for a housekeeping protein such as GAPDH or β-actin on the same membrane confirms equal loading. If studying extracellular HTRA-1, run unconditioned serum-free medium as a blank to rule out serum contamination. A no-primary-antibody control verifies that secondary antibody does not bind nonspecifically.

Does HTRA-1 have splice isoforms I should be aware of on Western blot?

HTRA-1 is encoded by a single-exon open reading frame with no well-characterized splice isoforms that produce stable, functional proteins. You should see one predominant band at approximately 50 kDa representing the mature secreted form. However, intracellular precursor forms with the signal peptide intact may run slightly higher, around 51–52 kDa, if your lysate captures nascent protein before cleavage. Polymorphisms in the promoter region (such as rs11200638) affect expression levels rather than protein size. If you observe multiple bands, consider proteolytic processing, post-translational modification heterogeneity, or degradation during sample preparation rather than alternative splicing.

Western blot validation for RP-HTRA1 — 4 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

HTRA-1: Kazal-Like domain — WB validation
WB · Panel 1 HTRA-1: Kazal-Like domain
HTRA-1: Catalytic domain — WB validation
WB · Panel 2 HTRA-1: Catalytic domain
HTRA-1: PDZ domain — WB validation
WB · Panel 3 HTRA-1: PDZ domain
HTRA-1: Carboxyterminal end — WB validation
WB · Panel 4 HTRA-1: Carboxyterminal end

Custom validation studies available on request — contact us.

Also known as:

  • High-temperature requirement A serine peptidase 1
  • Serine protease HTRA1
  • Serine protease 11
  • L56
  • HTRA1
  • EC 3.4.21.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →